Last reviewed · How we verify
Sinartrol (cinnoxicam)
Sinartrol (generic name: cinnoxicam) is a Nonsteroidal Anti-inflammatory Drug drug. It is currently in unknown development.
Sinartrol works by blocking the production of prostaglandins, which are hormone-like substances that cause pain and inflammation.
Sinartrol is a small molecule with the synonyms PIROXICAM CINNAMATE, PIROXICAM CINNAMIC ACID ESTER, and others. Its exact mechanism of action is not specified in the provided information.
At a glance
| Generic name | cinnoxicam |
|---|---|
| Drug class | Nonsteroidal Anti-inflammatory Drug |
| Therapeutic area | Pain |
| Phase | unknown |
Mechanism of action
Think of prostaglandins like messengers that tell your body to feel pain and become inflamed. When Sinartrol blocks these messengers, it helps to reduce pain and inflammation. This is similar to how aspirin works, but Sinartrol is a different type of medication.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sinartrol CI brief — competitive landscape report
- Sinartrol updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Sinartrol
What is Sinartrol?
How does Sinartrol work?
What is the generic name of Sinartrol?
What drug class is Sinartrol in?
What development phase is Sinartrol in?
Related
- Drug class: All Nonsteroidal Anti-inflammatory Drug drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Pain
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing